Regular Article
Coincubation of Bovine Synovial or Capsular Tissue with Cartilage Generates a Soluble “Aggrecanase” Activity

https://doi.org/10.1006/bbrc.1999.0266Get rights and content

Abstract

The culture of bovine synovial or capsular tissue generated proteoglycan-degrading activity. When these tissues were incubated with living or dead bovine articular cartilage significantly more proteoglycan-degrading activity was revealed. The activity was present in a soluble form and required protein synthesis for its generation. The conditioned medium did not contain matrixin activity, although experiments with proteinase inhibitors suggested that the activity was due to a metalloproteinase. Western blotting of the aggrecan fragments suggested cleavage of aggrecan within the interglobular domain at the “aggrecanase” site, but not at the major matrixin site. N-terminal sequencing confirmed cleavage of aggrecan at a number of glutamyl bonds, including the aggrecanase site in the interglobular domain. We conclude that cultured synovial or capsular tissue produces soluble aggrecanase and an enzyme which releases aggrecanase from cartilage, possibly by cleavage of a chondrocyte membrane-bound form of aggrecanase.

References (42)

  • E.R. Pettipher et al.

    Cytokine

    (1996)
  • A.R. Poole et al.
  • T.E. Cawston et al.

    Biochem. Biophys. Res. Commun.

    (1995)
  • M.A. Campbell et al.

    Arch. Biochem. Biophys.

    (1987)
  • C.R. Flannery et al.

    J. Biol. Chem.

    (1992)
  • M.W. Lark et al.

    J. Biol. Chem.

    (1995)
  • C.E. Hughes et al.

    J. Biol. Chem.

    (1997)
  • J.D. Sandy et al.

    J. Biol. Chem.

    (1991)
  • M.Z. Ilic et al.

    Arch. Biochem. Biophys.

    (1992)
  • H. Yamada et al.

    Biochem. Biophys. Res. Commun.

    (1995)
  • R.W. Farndale et al.

    Biochim. Biophys. Acta

    (1986)
  • C.J. Handley et al.

    Methods Enzymol.

    (1995)
  • H. Nagase et al.

    Anal. Biochem.

    (1980)
  • C.G. Knight et al.

    FEBS Lett.

    (1992)
  • M.J. Crossley et al.

    Biochem. Pharmacol.

    (1984)
  • A.H.K. Plaas et al.

    Matrix

    (1993)
  • M.Z. Ilic et al.

    J. Biol. Chem.

    (1998)
  • D.E. Woolley

    Mechanisms and Models in Rheumatoid Arthritis

    (1995)
  • J.C.W. Edwards
  • J.R. Ralphs et al.

    J. Anat.

    (1994)
  • Cited by (25)

    • Identifying the human aggrecanase

      2010, Osteoarthritis and Cartilage
      Citation Excerpt :

      Given the differences between the aetiopathogenesis of hip and knee OA19, it is not surprising that ADAMTS expression differs between knee and hip joints in humans15 and presumably differs also with stage of disease, although this has not been systematically examined. ADAMTS expression in cartilage represents only one part of the total joint picture, since ADAMTS enzymes are expressed in joint capsule and meniscus, as well as in synovium where ADAMTS expression is particularly well documented20–28. In distinct contrast to cartilage, both ADAMTS-4 and -5 are expressed constitutively in synovium and their expression by synovial fibroblasts is not regulated by IL-1 in vitro20,21,29.

    • Co-culture of mechanically injured cartilage with joint capsule tissue alters chondrocyte expression patterns and increases ADAMTS5 production

      2009, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      Nevertheless, it is possible that tissue from mature animals will behave differently in these injury models and this should be considered when making comparisons to other studies. Both synovium and joint capsule tissue generate a soluble aggrecan-degrading activity in vitro[30,31]. Higher aggrecanase-mediated cleavage potency was measured in medium from co-culture of synovium with either live or dead cartilage than that seen from synovium alone [30].

    • Western blot quantification of aggrecan fragments in human synovial fluid indicates differences in fragment patterns between joint diseases

      2009, Osteoarthritis and Cartilage
      Citation Excerpt :

      Secondly, joint cartilage is a major source of aggrecan fragments appearing in SF, but may not be the sole source; they may also to a variable extent originate from, e.g., menisci, ligaments and synovial tissue39–41. The synovial cells of the joint capsule contain aggrecanase activities42,43. Thirdly, we have assumed that aggrecan fragments appearing in SF are the result of proteolysis of resident, functional matrix molecules.

    • Effects of glucosamine on proteoglycan loss by tendon, ligament and joint capsule explant cultures

      2008, Osteoarthritis and Cartilage
      Citation Excerpt :

      In addition there was no effect on the proteolytic processing of large proteoglycans (data not shown). ADAMTS-4 and-5 are expressed in joint fibrous connective tissues and one or both of these proteinases may be responsible for the degradation of large aggregating proteoglycans in these tissues2,4,18,20,40–43. The lack of effect of glucosamine treatment in joint fibrous connective tissue explants is likely to be due to the difference in the regulation of aggrecanase activity in these tissues compared to cartilage.

    • The role of proteases in pathologies of the synovial joint

      2008, International Journal of Biochemistry and Cell Biology
    View all citing articles on Scopus

    Henderson, B.Edwards, J. C. W.Pettipher, E. R.

    1

    To whom correspondence should be addressed. Fax: (0)114 271 3781. E-mail:[email protected].

    View full text